Transcriptomics

Dataset Information

0

Recombinant and plasma-derived Factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A

ABSTRACT: To investigate the gene expression in dendritic cells after treating hemiphilic mice with HBSS, plasma derived or recombinant factor VIII Gene expression in dendritic cells were measured 24 hours post treatment

ORGANISM(S): Mus musculus

PROVIDER: GSE15809 | GEO | 2009/04/30

SECONDARY ACCESSION(S): PRJNA116721

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Recombinant and plasma-derived Factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A
2010-05-19 | E-GEOD-15809 | biostudies-arrayexpress
Unknown Current and emerging factor VIII replacement products for hemophilia A.
| S-EPMC5638175 | biostudies-literature
Unknown Potential role of a new PEGylated recombinant factor VIII for hemophilia A.
| S-EPMC4920230 | biostudies-literature
Unknown Recombinant VWF fragments improve bioavailability of subcutaneous factor VIII in hemophilia A mice.
| S-EPMC7952839 | biostudies-literature
Unknown Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
| S-EPMC3894491 | biostudies-literature
Unknown Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.
| S-EPMC3646317 | biostudies-literature
Unknown N-linked glycosylation modulates the immunogenicity of recombinant human factor VIII in hemophilia A mice.
| S-EPMC6278987 | biostudies-literature
Genomics Clostridium sp. DL-VIII
| PRJNA42093 | ENA
Genomics Analysis of Chromosome VIII of EC-C1 strains (S. cerevisiae)
2012-05-18 | GSE38034 | GEO
Unknown Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A.
| S-EPMC4551361 | biostudies-literature